Qing MaSummaryAffiliation: New South Wales Country: Australia Publications
| Collaborators
|
Detail Information
Publications
Acute kidney injury clinical trial design: old problems, new strategiesZoltan H Endre
Christchurch Kidney Research Group, Department of Medicine, University of Otago, Christchurch, New Zealand
Pediatr Nephrol 28:207-17. 2013..In particular, future trials should incorporate biomarkers specific to the etiology of the AKI, and treatment should match the phase of injury...
Test characteristics of urinary biomarkers depend on quantitation method in acute kidney injuryAzrina Md Ralib
Christchurch Kidney Research Group, Department of Medicine, University of Otago, Christchurch, New Zealand
J Am Soc Nephrol 23:322-33. 2012..The ideal method for quantitating biomarkers of urinary AKI depends on the outcome of interest...
Improved performance of urinary biomarkers of acute kidney injury in the critically ill by stratification for injury duration and baseline renal functionZoltan H Endre
Department of Medicine, Christchurch Kidney Research Group, University of Otago, Christchurch, New Zealand
Kidney Int 79:1119-30. 2011..68 and 0.78. Beyond 12 h, NGAL (0.71) and KIM-1 (0.66) performed best. Thus, the duration of injury and baseline renal function should be considered in evaluating biomarker performance to diagnose AKI...
Clearance and beyond: the complementary roles of GFR measurement and injury biomarkers in acute kidney injury (AKI)Zoltan H Endre
Christchurch Kidney Research Group, Department of Medicine, University of Otago, Christchurch, New Zealand
Am J Physiol Renal Physiol 301:F697-707. 2011..We predict that combining rapid measures of GFR with biomarkers of renal injury will yield substantive progress in the treatment of AKI...
